Dr. Moshe Ephrat is a fellowship trained and Board Certified surgeon with expertise and interests in facial plastic and reconstructive surgery as well as all aspects of ear, nose and throat surgery. He graduated from Albert Einstein College of Medicine in New York and then completed his residency in Otolaryngology-Head and Neck Surgery at Long Island Jewish Medical Center, of the Albert Einstein College of Medicine. In addition, Dr. Ephrat was awarded a fellowship devoted to facial plastic and reconstructive surgery with Dr. Fred Stucker.
Dr. Ephrat has over 15 years of experience and has special interests in rhinoplasty, sinus surgery, and facial rejuvenation using Botox and injectable fillers. Dr. Ephrat teaches surgeons in training with his academic appointments as an Assistant Clinical Professor for the Mount Sinai School of Medicine as well as the Hofstra North Shore - LIJ School of Medicine. He also has held a leadership position as the President of the Long Island Society of Otolaryngology - Head and Neck Surgery.
Dr. Ephrat is fortunate to be among the first in the area to offer a new breakthrough medical device for patient’s suffering from chronic sinusitis-PROPEL as well as the PolypVac. PolypVac allows IN-OFFICE treatment of nasal polyps and sinusitis. Chronic sinusitis is a condition in which patients’ sinuses become swollen and inflamed, leading to difficulty breathing, facial pain or headache, and loss of smell and taste. The condition is common, affecting 31 million people in the U.S., and greatly impacts quality of life. Although sinus surgery is an effective treatment for chronic sinusitis, the majority of patients experience recurrent symptoms within the first year and as many as 25 percent then undergo revision surgery due to recurrent obstruction of the sinus cavity.
Dr. Moshe Ephrat speaks with News 12 Long Island about early spring allergies and how to treat them click here!
The Propel implant is the only device in the industry backed by Level 1A evidence and proven to enhance and significantly improve outcomes. Please watch the below video for more information.
Dr. Ephrat now one of first on Long Island to perform new Spirox Latera implant for improved nasal breathing
This video below is about LATERA, a new FDA approved treatment for patients with nasal obstruction secondary to nasal valve stenosis or collapse. The implant is absorbable and supports the lateral wall cartilage, reducing collapse and obstruction. Dr. Ephrat is seen inserting the implant in this patient who also had a septoplasty (deviated septum repair) and turbinate reduction.
Published On: 12/16/2011
Published On: 12/05/2011
Published On: 10/22/2010